LAYOLIS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 24 Jan 2025)
What this means for you
Registered since 05 Dec 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87174405
- Registration number
- 5351657
- Mark type
- Stylized text
- Filed
- 16 Sept 2016
- Published for opposition
- 31 Jan 2017
- Registered
- 05 Dec 2017
- Attorney of record
- Laurence Rickles
Goods and services
- Class 005 — Pharmaceuticals: Oral contraceptive preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy
Owner
- ACTAVIS HOLDCO US, INC., PARSIPPANY, NJ, US
- Allergan Sales, LLC, Parsippany, NJ, US
- Allergan Sales, LLC, Parsippany, NJ, US
- Allergan Sales, LLC, Parsippany, NJ, US
Prosecution history
- 24 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 10 Jun 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 10 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Dec 2023 — TEAS SECTION 8 & 15 RECEIVED
- 05 Dec 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Feb 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Dec 2017 — REGISTERED-PRINCIPAL REGISTER
- 02 Nov 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Nov 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Oct 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Oct 2017 — USE AMENDMENT FILED
- 20 Oct 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Oct 2017 — TEAS STATEMENT OF USE RECEIVED